These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 147690)

  • 1. Effect of some Pteridine compounds on the Na+ + K+)-ATPase and on the cardiac glycoside receptor of human heart).
    Erdmann E; Krawietz W; Grosshans P
    Arzneimittelforschung; 1978; 28(2):298-9. PubMed ID: 147690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the action of triamterene on isolated cell membranes.
    Erdmann E; Krawietz W
    Arzneimittelforschung; 1976; 26(10):1812-7. PubMed ID: 139148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects on the mode of action of cardiac glycosides].
    Fricke U
    Fortschr Med; 1976 Nov; 94(32):1037-45. PubMed ID: 136410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart.
    Temma K; Akera T
    J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes].
    Erdmann E
    Arzneimittelforschung; 1978; 28(3a):531-5. PubMed ID: 148278
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischemia-induced enhancement of digitalis sensitivity in isolated guinea-pig heart.
    Kim DH; Akera T; Kennedy RH
    J Pharmacol Exp Ther; 1983 Aug; 226(2):335-42. PubMed ID: 6308206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of the exchange of Na+ for K+ and and H+ by triamterene (in epithelia)(author's transl)].
    Knauf H; Wais U; Albiez G; Lübcke R
    Arzneimittelforschung; 1976 Apr; 26(4):484-6. PubMed ID: 133688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basis of the active mechanism of cardioactive glycoside].
    Schoner W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():6-18. PubMed ID: 148185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiac effects of antikaliuretic diuretics-clinical and biochemical investigation (author's transl)].
    Erdmann E; Krawietz W; Poppert D; Krüger R; von Arnim T; Vogt W; Bolte HD
    Klin Wochenschr; 1977 Oct; 55(20):985-94. PubMed ID: 144825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na+, K+-ATPase of the canine mesenteric artery.
    Wallick ET; Adams RJ; Fondacaro JD; Jacobson ED
    Fed Proc; 1982 Apr; 41(6):2101-5. PubMed ID: 6281071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
    Ozaki H; Nagase H; Urakawa N
    J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of the Na-K-ATPase of guinea-pig heart microsomes by cardiac glycosides.
    Godfraind T; De Pover A
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):197-200. PubMed ID: 4268671
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation of cardiac glycoside binding to their receptors and inhibition of (Na + K)-active ATPase. Clinical significance and application possibilities].
    Erdmann E; Schoner W
    Verh Dtsch Ges Inn Med; 1974; 80():1075-7. PubMed ID: 4281574
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in cardiac glycoside-Na+,K+-ATPase interaction.
    Wallick ET; Lindenmayer GE; Lane LK; Allen JC; Pitts BJ; Schwartz A
    Fed Proc; 1977 Aug; 36(9):2214-8. PubMed ID: 142025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
    Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of affinity and capacity of cardiac glycoside receptors].
    Erdmann E
    Arzneimittelforschung; 1985; 35(12A):1948-52. PubMed ID: 3913428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats.
    Akera T; Hook JB; Tobin T; Brody TM
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):699-706. PubMed ID: 4264311
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial mitogenic effect of erythropoietin through the activation of Na(+)-K(+)-ATPase activity.
    Sterin-Borda L; Wald M; Gutnisky A; Casanova M; Arana R; Borda E
    Acta Physiol Pharmacol Ther Latinoam; 1994; 44(1-2):1-10. PubMed ID: 7640398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of rat kidney plasma membrane Na-K-ATPase activity by triamterene.
    Ozegović B; Milković S
    Arzneimittelforschung; 1982; 32(10):1279-81. PubMed ID: 6129855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of potassium in the inhibition by cardiac glycosides of (Na+-K+)-ATPase prepared from human heart [(proceedings)].
    De Pover A; Godfraind T
    Br J Pharmacol; 1976 Nov; 58(3):413P-414P. PubMed ID: 136282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.